DiPaolo J A, Evans C H, DeMarinis A J, Doniger J
Int J Cancer. 1982 Dec 15;30(6):781-5. doi: 10.1002/ijc.2910300617.
Phytohemagglutinin (PHA) or either of its isolectins, erythroagglutinin or leukoagglutinin, causes a dose-dependent decrease in 12-0-tetradecanoylphorbol 13-acetate (TPA)-promoted transformation of Syrian hamster embryo cells, but has no effect on transformation induced by ultraviolet irradiation. The ineffectiveness of concanavalin A indicates that not every lectin inhibits TPA. Galactose, a dominant sugar in receptors for PHA binding, reverses the inhibition of TPA promotion caused by PHA but galactose does not inhibit TPA promotion itself. Therefore, the TPA and PHA binding sites are functionally discrete. The PHA inhibition of TPA-promoted transformation is reversible because PHA is only effective if present with TPA, whereas lymphotoxin, an immunologic hormone, has a persistent anti-carcinogenic effect, regardless of whether it is added before or after TPA. PHA in conjunction with lymphotoxin causes additional inhibition of TPA-promoted transformation. PHA and lymphotoxin affect the biological activity of TPA by diverse mechanisms. Lymphotoxin alters the physiological state of the cell, causing a change in the cellular response to TPA. PHA may affect either the binding of TPA to a critical cellular receptor for promotion or a later step in promotion.
植物血凝素(PHA)或其两种同工凝集素(红细胞凝集素或白细胞凝集素)会使十四烷酰佛波醇乙酯(TPA)促进的叙利亚仓鼠胚胎细胞转化呈剂量依赖性降低,但对紫外线照射诱导的转化没有影响。伴刀豆球蛋白A无效表明并非每种凝集素都会抑制TPA。半乳糖是PHA结合受体中的主要糖类,它能逆转PHA对TPA促进作用的抑制,但半乳糖本身不会抑制TPA促进作用。因此,TPA和PHA的结合位点在功能上是分开的。PHA对TPA促进转化的抑制是可逆的,因为PHA只有与TPA同时存在时才有效,而免疫激素淋巴毒素具有持久的抗癌作用,无论它在TPA之前还是之后添加。PHA与淋巴毒素共同作用会进一步抑制TPA促进的转化。PHA和淋巴毒素通过不同机制影响TPA的生物活性。淋巴毒素改变细胞的生理状态,导致细胞对TPA的反应发生变化。PHA可能会影响TPA与促进转化的关键细胞受体的结合,或者影响促进过程中的后续步骤。